Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
38M
-
Shares change
-
+913
-
Total reported value, excl. options
-
$897M
-
Value change
-
-$28.8K
-
Number of buys
-
75
-
Number of sells
-
-63
-
Price
-
$23.64
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q2 2021
179 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q2 2021.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38M shares
.
Largest 10 shareholders include BlackRock Inc. (5.67M shares), JANUS HENDERSON GROUP PLC (4.09M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.63M shares), Rubric Capital Management LP (2.42M shares), VANGUARD GROUP INC (2.24M shares), Camber Capital Management LP (2M shares), RENAISSANCE TECHNOLOGIES LLC (1.25M shares), STATE STREET CORP (1.15M shares), PRINCIPAL FINANCIAL GROUP INC (1.03M shares), and PERCEPTIVE ADVISORS LLC (978K shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.